ApoA-I Nanotherapy Rescues Postischemic Vascular Maladaptation by Modulating Endothelial Cell and Macrophage Phenotypes in Type 2 Diabetic Mice

Seppo Ylä-Herttuala

Correspondence to: Seppo Ylä-Herttuala, MD, PhD, Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Eastern Finland, FIN-70211 Kuopio, Finland. Email

E-mail Address: [email protected]

Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Eastern Finland, Kuopio (M.B., D.D., P.M., T.O., E.A., M.K., S.Y.-H.).

Heart Center and Gene Therapy Unit, Kuopio University Hospital, Finland (S.Y.-H.).

Comments (0)

No login
gif